ALK POSITIVE
Clinical trials for ALK POSITIVE explained in plain language.
Never miss a new study
Get alerted when new ALK POSITIVE trials appear
Sign up with your email to follow new studies for ALK POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Early trial tests drug combo to stall advanced cancers
Disease control OngoingThis early-stage study aims to find the safest and most effective dose of two oral drugs, ceritinib and everolimus, when used together. It is for adults with advanced solid tumors that have spread, including a specific type of lung cancer. The main goal is to understand the side …
Matched conditions: ALK POSITIVE
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 04, 2026 04:51 UTC
-
Drug trial aims to stop lung Cancer's comeback after surgery
Disease control OngoingThis study is testing whether a drug called crizotinib can help prevent cancer from returning in people with early-stage lung cancer who have had surgery to remove their tumor. It is for patients whose cancer has a specific genetic change called ALK-positive. Participants are ran…
Matched conditions: ALK POSITIVE
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC